SAN DIEGO, May 7, 2008
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES PRICING OF COMMON STOCK AND WARRANT UNIT OFFERING

SAN DIEGO, May 1, 2008
LA JOLLA PHARMACEUTICAL COMPANY REPORTS FIRST QUARTER FINANCIAL RESULTS

SAN DIEGO, April 23, 2008
LA JOLLA PHARMACEUTICAL ANNOUNCES POSITIVE 12-MONTH INTERIM ANTIBODY DATA AND PROVIDES UPDATE FOR ONGOING RIQUENT® PHASE 3 "ASPEN" LUPUS TRIAL

SAN DIEGO, February 28, 2008
LA JOLLA PHARMACEUTICAL COMPANY REPORTS FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS

SAN DIEGO, February 28, 2008
LA JOLLA PHARMACEUTICAL COMPANY TO PRESENT AT SUSQUEHANNA FINANCIAL GROUP HEALTHCARE CONFERENCE

SAN DIEGO, February 11, 2008
LA JOLLA PHARMACEUTICAL COMPANY REPORTS PROGRESS IN INTERNATIONAL PHASE 3 RIQUENT® STUDY

SAN DIEGO, February 6, 2008
LA JOLLA PHARMACEUTICAL COMPANY TO PRESENT AT BIO CEO INVESTOR CONFERENCE